This HTML5 document contains 27 embedded RDF statements represented using HTML+Microdata notation.
The embedded RDF content will be recognized by any processor of HTML5 Microdata.
Namespace Prefixes
Prefix | IRI |
n4 | http://linked.opendata.cz/resource/mesh/concept/ |
rdfs | http://www.w3.org/2000/01/rdf-schema# |
rdf | http://www.w3.org/1999/02/22-rdf-syntax-ns# |
owl | http://www.w3.org/2002/07/owl# |
n3 | http://linked.opendata.cz/ontology/mesh/ |
nci | http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl# |
xsdh | http://www.w3.org/2001/XMLSchema# |
Statements
- Subject Item
- nci:C2320
- rdf:type
-
owl:Class
- rdfs:label
-
Teroxirone
- rdfs:subClassOf
-
nci:C475
- nci:A8
-
nci:C63923
- nci:P106
-
Organic Chemical
Pharmacologic Substance
- nci:P108
-
Teroxirone
- nci:P175
-
296934
- nci:P207
-
C0043891
- nci:P210
-
59653-73-5
- nci:P303
-
Advanced Malignancies Confined to the Abdominal and Peritoneal Cavity.
- nci:P319
-
456V4159SL
- nci:P322
-
FDA
- nci:P329
-
39722
- nci:P330
-
39722
- nci:P350
-
C12H15N3O6
- nci:P366
-
Teroxirone
- nci:P90
-
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Teroxirone</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>alpha-1,3,5-triglycidyl-s-triazinetrione</n0:term-name><n0:term-group>SN</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>alpha-TGI</n0:term-name><n0:term-group>SN</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Teroxirone</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>DTP</n0:term-source><n0:source-code>NSC0296934</n0:source-code></n0:ComplexTerm>
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Henkel's Compound</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>TEROXIRONE</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>FDA</n0:term-source><n0:source-code>456V4159SL</n0:source-code></n0:ComplexTerm>
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>alpha-Triglycidyl Isocyanurate</n0:term-name><n0:term-group>SN</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
- nci:P97
-
<n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A triazene triepoxide with antineoplastic activity. Teroxine alkylates and cross-links DNA, thereby inhibiting DNA replication. (NCI04)</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
- nci:code
-
C2320
- n3:hasConcept
-
n4:M0092302